Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Non-Current Debt (2019 - 2025)

BioCorRx's Non-Current Debt history spans 7 years, with the latest figure at $69803.0 for Q3 2025.

  • For Q3 2025, Non-Current Debt changed N/A year-over-year to $69803.0; the TTM value through Sep 2025 reached $69803.0, changed N/A, while the annual FY2024 figure was $71029.0, N/A changed from the prior year.
  • Non-Current Debt for Q3 2025 was $69803.0 at BioCorRx, down from $71029.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $71029.0 in Q4 2024 and bottomed at $69803.0 in Q3 2025.